ADAR1 CAPITAL MANAGEMENT : CALLS FOR RETURN OF $475 MILLION TO STOCKHOLDERS BY Q3 2025 FOR KEROS THERAPEUTICS
ADAR1 CAPITAL MANAGEMENT: PLANS TO NOMINATE NEW DIRECTORS FOR 2026 ANNUAL MEETING OF KEROS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.